Enhancing mental health literacy in obsessive-compulsive disorder and reducing stigma via smartphone: A randomized controlled trial protocol

被引:14
|
作者
Chaves, Antonio [1 ]
Arnaez, Sandra [1 ,2 ]
Castilla, Diana [1 ,3 ]
Roncero, Maria [1 ]
Garcia-Soriano, Gemma [1 ]
机构
[1] Univ Valencia, Dept Personalidad Evaluat & Tratamientos Psicol, Avda Blasco Ibanez 21, Valencia 46010, Spain
[2] Univ Nacl Educ Distancia UNED, Dept Psicol Personalidad Evaluac & Tratamiento Ps, C Juan del Rosal 14, Madrid 28040, Spain
[3] ISCIII CB06 03 0052 Inst Salud Carlos III, CIBER Physiopathol Obes & Nutr CIBEROBN, Madrid 28029, Spain
关键词
OCD; RCT; Stigma; Mental health literacy; Help-seeking intention; App; INTRUSIVE THOUGHTS; SYMPTOM DIMENSIONS; UNTREATED ILLNESS; TREATMENT-SEEKING; HELP-SEEKING; METAANALYSIS; APPRAISALS; DURATION; IMPACT;
D O I
10.1016/j.invent.2022.100560
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background: Obsessive-compulsive disorder (OCD) is a disabling disorder that can be successfully treated. However, individuals with OCD do not seek or delay seeking treatment. This delay may be explained by poor mental health literacy and stigmatizing attitudes toward OCD in community. In order to work on these variables, a gamified mental health mobile application (app) called esTOCma has been developed. The purpose of this study is to describe the protocol for a study to test the efficacy of esTOCma, increasing mental health literacy and help-seeking intention, reducing the stigmatizing attitudes and social distance suffered by people with OCD, as well as the distress associated with obsessive-compulsive symptoms. Methods: A randomized controlled trial with a crossover design with two conditions (immediate-use App group versus delayed-use App group) will be conducted on a non-clinical adult sample of the community of a minimum size of 200 participants. Participants in the immediate-use App group will start using the app at baseline until completion (10 days); whereas participants in the delayed-use App group will wait 10 days, and then start using the app until completion (10 days). The outcomes will be measured at four assessment points (baseline; 10 days from baseline; and 20 days from baseline; and after 3 months). The following instruments will be administered: Attribution Questionnaire, General Help-Seeking Questionnaire, Social Distance Scale, Mental Health Literacy, Psychoeducation Questionnaire, Social Desirability Scale, Single-Item Self-esteem Scale, and Obsessive-Compulsive Inventory-Revised. Discussion: This protocol presents the first study to describe a randomized control trial of a mental health app focused on changing mental health literacy, stigmatizing attitudes, social distance and help-seeking intention associated with OCD. An app intervention of these characteristics is especially relevant nowadays as the COVID-19 pandemic has increased obsessive-compulsive symptoms and severity. An improvement in general knowledge about OCD and a reduction in stigma could be associated with earlier OCD detection and an increase in help-seeking intention, which could result in greater wellbeing. Moreover, normalizing intrusions and knowledge about the cognitive OCD model could serve as a protective variable in vulnerable individuals.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Mental Health Literacy and Stigma Among Salvadorian Youth: Anxiety, Depression and Obsessive-Compulsive Related Disorders
    Nora Trompeter
    Carly Johnco
    Raquel M. Zepeda-Burgos
    Sophie C. Schneider
    Sandra L. Cepeda
    Valérie La Buissonniѐre-Ariza
    Daniel Guttfreund
    Eric A. Storch
    Child Psychiatry & Human Development, 2022, 53 : 48 - 60
  • [22] Mental Health Literacy and Stigma Among Salvadorian Youth: Anxiety, Depression and Obsessive-Compulsive Related Disorders
    Trompeter, Nora
    Johnco, Carly
    Zepeda-Burgos, Raquel M.
    Schneider, Sophie C.
    Cepeda, Sandra L.
    La Buissonniere-Ariza, Valerie
    Guttfreund, Daniel
    Storch, Eric A.
    CHILD PSYCHIATRY & HUMAN DEVELOPMENT, 2022, 53 (01) : 48 - 60
  • [23] Randomized Controlled Crossover Trial of Ketamine in Obsessive-Compulsive Disorder: Proof-of-Concept
    Rodriguez, Carolyn I.
    Kegeles, Lawrence S.
    Levinson, Amanda
    Feng, Tianshu
    Marcus, Sue M.
    Vermes, Donna
    Flood, Pamela
    Simpson, Helen B.
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 (12) : 2475 - 2483
  • [24] Randomized Controlled Crossover Trial of Ketamine in Obsessive-Compulsive Disorder: Proof-of-Concept
    Carolyn I Rodriguez
    Lawrence S Kegeles
    Amanda Levinson
    Tianshu Feng
    Sue M Marcus
    Donna Vermes
    Pamela Flood
    Helen B Simpson
    Neuropsychopharmacology, 2013, 38 : 2475 - 2483
  • [25] A pilot randomized controlled trial of videoconference-assisted treatment for obsessive-compulsive disorder
    Vogel, Patrick A.
    Solem, Stian
    Hagen, Kristen
    Moen, Erna M.
    Launes, Gunvor
    Haland, Ashild T.
    Hansen, Bjarne
    Himle, Joseph A.
    BEHAVIOUR RESEARCH AND THERAPY, 2014, 63 : 162 - 168
  • [26] "Association splitting" versus cognitive remediation in obsessive-compulsive disorder: A randomized controlled trial
    Jelinek, Lena
    Hauschildt, Marit
    Hottenrott, Birgit
    Kellner, Michael
    Moritz, Steffen
    JOURNAL OF ANXIETY DISORDERS, 2018, 56 : 17 - 25
  • [27] Updated Results of a Randomized Controlled Trial of Gamma Ventral Capsulotomy for Obsessive-Compulsive Disorder
    Lopes, Antonio C.
    Batistuzzo, Marcelo C.
    Canteras, Miguel M.
    de Mathis, Maria E.
    Joaquim, Marines
    D'Alcante, Carina C.
    Taub, Anita
    Duran, Fabio F. L. S.
    Hoexter, Marcelo Q.
    Greenberg, Benjamin D.
    Noren, Georg
    Rasmussen, Steven A.
    Shavitt, Roseli G.
    Miguel, Euripedes C.
    BIOLOGICAL PSYCHIATRY, 2011, 69 (09) : 275S - 275S
  • [28] Minority participation in randomized controlled trials for obsessive-compulsive disorder
    Williams, Monnica
    Powers, Mark
    Yun, Yeo-Gin
    Foa, Edna
    JOURNAL OF ANXIETY DISORDERS, 2010, 24 (02) : 171 - 177
  • [29] A promising randomized trial of a new therapy for obsessive-compulsive disorder
    Hu, Xian-Zhang
    Wen, You-Sheng
    Ma, Jian-Dong
    Han, Dong-Ming
    Li, Yu-Xia
    Wang, Shu-Fan
    BRAIN AND BEHAVIOR, 2012, 2 (04): : 443 - 454
  • [30] A controlled trial of fluvoxamine for obsessive-compulsive disorder in children and adolescents
    Riddle, MA
    Claghorn, J
    Gaffney, G
    Griest, JH
    Holland, D
    Landbloom, R
    McConville, B
    Pigott, T
    Pravetz, M
    Walkup, JT
    YaryuraTobias, J
    Houser, VP
    PSYCHOPHARMACOLOGY BULLETIN, 1996, 32 (03) : 399 - 399